Iradimed (IRMD) Cash from Investing Activities (2016 - 2026)
Iradimed has reported Cash from Investing Activities over the past 14 years, most recently at -$469000.0 for Q1 2026.
- Quarterly Cash from Investing Activities rose 88.03% to -$469000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.0 million through Mar 2026, up 59.42% year-over-year, with the annual reading at -$8.4 million for FY2025, 4.49% up from the prior year.
- Cash from Investing Activities was -$469000.0 for Q1 2026 at Iradimed, down from -$416407.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $77561.0 in Q2 2022 and troughed at -$6.6 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$556188.0 (2022), against an average of -$1.6 million.
- Year-over-year, Cash from Investing Activities crashed 1443.94% in 2023 and then soared 92.7% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$471676.0 in 2022, then crashed by 34.16% to -$632816.0 in 2023, then crashed by 383.07% to -$3.1 million in 2024, then surged by 86.38% to -$416407.0 in 2025, then fell by 12.63% to -$469000.0 in 2026.
- Per Business Quant, the three most recent readings for IRMD's Cash from Investing Activities are -$469000.0 (Q1 2026), -$416407.0 (Q4 2025), and -$1.3 million (Q3 2025).